HomeCompareMET vs CTSH

MET vs CTSH: Dividend Comparison 2026

MET yields 3.33% · CTSH yields 2.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTSH wins by $27.7K in total portfolio value· pulled ahead in Year 5
10 years
MET
MET
● Live price
3.33%
Share price
$68.27
Annual div
$2.27
5Y div CAGR
23%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.3K
Annual income
$4,879.85
Full MET calculator →
CTSH
CTSH
● Live price
2.06%
Share price
$61.06
Annual div
$1.26
5Y div CAGR
42.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.0K
Annual income
$18,542.84
Full CTSH calculator →

Portfolio growth — MET vs CTSH

📍 CTSH pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMETCTSH
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MET + CTSH cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MET pays
CTSH pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MET
Annual income on $10K today (after 15% tax)
$282.63/yr
After 10yr DRIP, annual income (after tax)
$4,147.87/yr
CTSH
Annual income on $10K today (after 15% tax)
$175.40/yr
After 10yr DRIP, annual income (after tax)
$15,761.41/yr
At 15% tax rate, CTSH beats the other by $11,613.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MET + CTSH for your $10,000?

MET: 50%CTSH: 50%
100% CTSH50/50100% MET
Portfolio after 10yr
$55.2K
Annual income
$11,711.34/yr
Blended yield
21.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MET right now

MET
Analyst Ratings
24
Buy
8
Hold
Consensus: Buy
Price Target
$96.83
+41.8% upside vs current
Range: $90.00 — $101.00
Altman Z
0.1
Piotroski
8/9
CTSH
Analyst Ratings
22
Buy
24
Hold
5
Sell
Consensus: Hold
Price Target
$91.00
+49.0% upside vs current
Range: $71.00 — $107.00
Altman Z
6.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MET buys
8
CTSH buys
0
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$MET▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$MET▼ Sell$1,000 - $15,0002025-08-26
Gilbert Cisneros🏢 House$MET▼ Sell$1,001 - $15,0002025-08-06
Ritchie Torres🏢 House$MET▼ Sell$1,001 - $15,0002025-07-11
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002025-06-13
Sheldon Whitehouse🏛 Senate$MET▼ Sell$1,001 - $15,0002024-11-19
Thomas R. Carper🏛 Senate$MET▼ Sell$1,001 - $15,0002024-01-17
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002023-10-31
Sheldon Whitehouse🏛 Senate$MET▼ Sell$1,001 - $15,0002023-09-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMETCTSH
Forward yield3.33%2.06%
Annual dividend / share$2.27$1.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR23%42.7%
Portfolio after 10y$41.3K$69.0K
Annual income after 10y$4,879.85$18,542.84
Total dividends collected$18.1K$44.3K
Payment frequencyquarterlyquarterly
SectorFinancialsTechnology
Analyst consensusBuyHold
Analyst price target$96.83$91.00

Year-by-year: MET vs CTSH ($10,000, DRIP)

YearMET PortfolioMET Income/yrCTSH PortfolioCTSH Income/yrGap
1$11,109$408.98$10,994$294.47+$115.00MET
2$12,409$522.27$12,196$431.77+$213.00MET
3$13,948$670.62$13,688$638.75+$260.00MET
4$15,791$866.52$15,603$956.11+$188.00MET
5← crossover$18,024$1,127.71$18,148$1,453.43$124.00CTSH
6$20,765$1,479.66$21,673$2,254.62$908.00CTSH
7$24,179$1,959.61$26,781$3,590.89$2.6KCTSH
8$28,494$2,622.90$34,574$5,917.65$6.1KCTSH
9$34,042$3,553.25$47,182$10,188.34$13.1KCTSH
10$41,305$4,879.85$69,028$18,542.84$27.7KCTSH

MET vs CTSH: Complete Analysis 2026

METFinancials

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Full MET Calculator →

CTSHTechnology

Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies. It also provides solution to manufacturers, retailers and travel and hospitality companies, as well as companies providing logistics, energy and utility services; and digital content, the creation of personalized user experience, and acceleration of digital engineering services to information, media and entertainment, and communications and technology companies. The company was founded in 1994 and is headquartered in Teaneck, New Jersey.

Full CTSH Calculator →
📬

Get this MET vs CTSH comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MET vs SCHDMET vs JEPIMET vs OMET vs KOMET vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.